These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 10599357)

  • 1. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatment.
    Ostrowski S; Chibowska M; Biłan A; Palusiński R; Weglarz J; Makaruk B; Krasowska D; Hanzlik J
    Adv Exp Med Biol; 1999; 455():289-93. PubMed ID: 10599357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): echocardiographic substudy--three months follow-up.
    Biłan A; Chibowska M; Makaruk B; Palusiński R; Weglarz J; Ostrowski S; Witczak A; Hanzlik J; Krasowska D
    Adv Exp Med Biol; 1999; 455():279-83. PubMed ID: 10599355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): electrocardiographic substudy--three months follow-up.
    Paulisiński R; Chibowska M; Biłan A; Ostrowski S; Weglarz J; Krasowska D; Hanzlik J
    Adv Exp Med Biol; 1999; 455():295-8. PubMed ID: 10599358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): ECG exercise testing--three months follow-up.
    Biłan A; Chibowska M; Palusiński R; Witczak A; Ostrowski S; Makaruk B; Weglarz J; Hanzlik J; Krasowska D
    Adv Exp Med Biol; 1999; 455():285-8. PubMed ID: 10599356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of enalapril on exercise capacity and right ventricular function in patients with chronic cor pulmonale].
    Pérez-Calvo J; Civeira F; Ferrando J; Martínez-Rodés P; Torralba MA; Banzo J; Prats E; Bueno J
    An Med Interna; 2000 Oct; 17(10):527-32. PubMed ID: 11109647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
    Kaiser T; Heise T; Nosek L; Eckers U; Sawicki PT
    J Hypertens; 2006 Jul; 24(7):1397-403. PubMed ID: 16794490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study.
    Di Marco F; Guazzi M; Vicenzi M; Santus P; Cazzola M; Pappalettera M; Castellotti P; Centanni S
    Pulm Pharmacol Ther; 2010 Jun; 23(3):159-64. PubMed ID: 20096799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
    Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The comparison of the effect of enalapril and indapamide on the peripheral blood pressure and central blood pressure through pulse wave analysis].
    Jiang XJ; Li QY; Zhang YQ; Liu GZ; Liu LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):885-8. PubMed ID: 16266472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
    Rake EC; Breeze E; Fletcher AE
    J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
    Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
    Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.